Correlation Between Xander International and BRIM Biotechnology

Can any of the company-specific risk be diversified away by investing in both Xander International and BRIM Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xander International and BRIM Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xander International and BRIM Biotechnology, you can compare the effects of market volatilities on Xander International and BRIM Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xander International with a short position of BRIM Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xander International and BRIM Biotechnology.

Diversification Opportunities for Xander International and BRIM Biotechnology

-0.19

Correlation Coefficient

Xander International  BRIM Biotechnology

Good diversification

The 3 months correlation between Xander and BRIM is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Xander International and BRIM Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BRIM Biotechnology and Xander International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xander International are associated (or correlated) with BRIM Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BRIM Biotechnology has no effect on the direction of Xander International i.e., Xander International and BRIM Biotechnology go up and down completely randomly.

Pair Corralation between Xander International and BRIM Biotechnology

Assuming the 90 days trading horizon Xander International is expected to under-perform the BRIM Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Xander International is 1.72 times less risky than BRIM Biotechnology. The stock trades about -0.03 of its potential returns per unit of risk. The BRIM Biotechnology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  4,700  in BRIM Biotechnology on October 4, 2024 and sell it today you would lose (1,600) from holding BRIM Biotechnology or give up 34.04% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.58%
Values	Daily Returns

Xander International  vs.  BRIM Biotechnology

Xander International

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Xander International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Xander International is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

BRIM Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Xander International and BRIM Biotechnology

The main advantage of trading using opposite Xander International and BRIM Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xander International position performs unexpectedly, BRIM Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BRIM Biotechnology will offset losses from the drop in BRIM Biotechnology's long position.

The idea behind Xander International and BRIM Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.